Advertisement

Abstract

Tinea capitis occurs primarily in children with a peak incidence between 5–8 years of age.

Keywords

Atopic Dermatitis Antifungal Agent Alopecia Areata Tinea Capitis Wood Light 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Degreef H.: The changing spectrum of tinea capitis. Current Opinion in Dermatology 3:44–48 (1996)Google Scholar
  2. Friedlander S.F, Aly R., Krafchik B., Blumer J., Honig P., Steward D., Lucky A.W., Gupta A.K., Babel D.E., Abrams B., Gourmala N., Wraith L., Paul C. and the Tinea capitis Study Group: Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 109:602–607 (2002)PubMedCrossRefGoogle Scholar
  3. Ginter G.: Microsporum canis infections in children: results of a new oral antifungal therapy. Mycoses 39:265–269 (1996)PubMedCrossRefGoogle Scholar
  4. Gupta A.K., Ginter G: Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol 18:519–522 (2001)PubMedCrossRefGoogle Scholar
  5. Herbert A.A.: Diagnosis and treatment of tinea capitis in children. Dermatologic Therapy 2:78–83 (1997)Google Scholar
  6. Higgins E.M., Fuller L.C., Smith C.H.: Guidelines for the management of tinea capitis. British Journal of Dermatology 143:53–58 (2000)PubMedCrossRefGoogle Scholar
  7. Koumantaki E., Georgala S., Rallis E., Papadavid E.: Microsporum canis tinea capitis in an 8-monthold infant successfully treated with 2 weekly pulses of oral itraconazole. Pediatric Dermatology 18:60–62 (2001)PubMedCrossRefGoogle Scholar
  8. Lipozencic J., Skerlev M., Orofino-Costa R., Zaitz V. C., Horvath A., Chouela E., Romero G., Gourmala N., Paul C., and the Tinea capitis Study Group: A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol 146:816–823 (2002)PubMedCrossRefGoogle Scholar
  9. Mercurio M.G., Elewski B.: Tinea capitis treatment. Dermatologic Therapy 3:79–83 (1997)Google Scholar
  10. Möhrenschlager M., Schnopp C., Fesq H., Strom K., Beham A., Mempel M., Thomsen S., Brockow K., Wessner D.B., Heidelberger A., Ruhdorfer S., Weigl L., Seidl H. P., Ring J., Abeck D.: Optimizing the therapeutic approach in tinea capitis of childhood., British Journal of Dermatology 143:1011–1015 (2000)PubMedCrossRefGoogle Scholar
  11. Richardson M.D., Warnock D.M.: Fungal infections. Diagnosis and management, 2nd. ed. Blackwell Science, Oxford (1997)Google Scholar
  12. Suarez S., Friedlander S.E: Antifungal therapy in children: an update. Pediatric Annals 27:177–184 (1998)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • D. Abeck

There are no affiliations available

Personalised recommendations